| New Enterprise Associates 16, L.P. |
Non-Executive |
Marker Therapeutics, Inc. (MRKR)
|
2024-12-23 |
$3.20 |
0.0% |
554,250
|
$1,773,600 |
| New Enterprise Associates 16, L.P. |
Non-Executive |
Trevi Therapeutics, Inc. (TRVI)
|
2022-04-11 |
$1.90 |
63.2% |
2,631,578
|
$4,999,998 |
| New Enterprise Associates 16, L.P. |
Non-Executive |
Marker Therapeutics, Inc. (MRKR)
|
2021-03-16 |
$17.50 |
-82.1% |
571,428
|
$9,999,999 |
| New Enterprise Associates 16, L.P. |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2020-09-18 |
$13.00 |
-95.5% |
769,230
|
$9,999,990 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-54.6% |
$-14,606,294 |
$26,773,587 |